SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: DaiS who wrote (9279)6/7/1998 5:39:00 AM
From: Sal Milani  Respond to of 23519
 
DaiS - <How did you decide R=250 dollars in your equation?>
I tried to make a conservative estimate. The retail cost in the US as I understand it is about $20/dose but I don't know what Vivus's share is. I'm sure also that the retail price will drop in the future. Also the frequency of use is also a guess. I just took $5/week for 50 weeks. I think this is very low. I would appreciate a better number.
Sal